László Farkas

4.5k total citations
93 papers, 3.4k citations indexed

About

László Farkas is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, László Farkas has authored 93 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 14 papers in Surgery. Recurrent topics in László Farkas's work include Pulmonary Hypertension Research and Treatments (32 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers) and Neonatal Respiratory Health Research (12 papers). László Farkas is often cited by papers focused on Pulmonary Hypertension Research and Treatments (32 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers) and Neonatal Respiratory Health Research (12 papers). László Farkas collaborates with scholars based in United States, Hungary and Canada. László Farkas's co-authors include Martin Kolb, Norbert F. Voelkel, Jack Gauldie, Daniela Farkas, Harm Jan Bogaard, Jose Gomez‐Arroyo, Donatas Kraskauskas, Kjetil Ask, Aysar Alhussaini and Peter J. Margetts and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

László Farkas

89 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Farkas United States 31 2.1k 823 629 473 345 93 3.4k
Brian B. Graham United States 35 2.4k 1.1× 828 1.0× 790 1.3× 479 1.0× 324 0.9× 105 3.7k
Clemens Ruppert Germany 39 2.7k 1.3× 1.0k 1.2× 234 0.4× 325 0.7× 330 1.0× 113 4.4k
Yuh Fukuda Japan 33 1.5k 0.7× 720 0.9× 259 0.4× 712 1.5× 458 1.3× 137 3.7k
Hidenori Nakamura Japan 29 1.9k 0.9× 664 0.8× 219 0.3× 371 0.8× 898 2.6× 166 3.8k
Philipp Markart Germany 36 2.0k 1.0× 841 1.0× 199 0.3× 259 0.5× 441 1.3× 85 4.0k
Kjetil Ask Canada 36 2.5k 1.2× 1.3k 1.5× 210 0.3× 488 1.0× 497 1.4× 94 4.7k
Huaping Dai China 28 1.4k 0.6× 594 0.7× 185 0.3× 351 0.7× 376 1.1× 144 2.4k
Kazuhiro Watanabe Japan 33 861 0.4× 659 0.8× 996 1.6× 1.2k 2.4× 158 0.5× 182 3.5k
Jacques Caen France 39 1.2k 0.6× 1.2k 1.4× 711 1.1× 633 1.3× 364 1.1× 160 5.0k
Helmut Unruh Canada 32 1.5k 0.7× 885 1.1× 194 0.3× 650 1.4× 839 2.4× 76 3.5k

Countries citing papers authored by László Farkas

Since Specialization
Citations

This map shows the geographic impact of László Farkas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Farkas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Farkas more than expected).

Fields of papers citing papers by László Farkas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Farkas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Farkas. The network helps show where László Farkas may publish in the future.

Co-authorship network of co-authors of László Farkas

This figure shows the co-authorship network connecting the top 25 collaborators of László Farkas. A scholar is included among the top collaborators of László Farkas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Farkas. László Farkas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeudall, W. Andrew, et al.. (2024). Liposomes-Encapsulating Double-Stranded Nucleic Acid (Poly I:C) for Head and Neck Cancer Treatment. ACS Pharmacology & Translational Science. 7(5). 1612–1623. 3 indexed citations
2.
Ali, Mehboob, Mingjun Liu, Neil J. Kelly, et al.. (2023). A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3. iScience. 26(2). 105935–105935. 11 indexed citations
3.
4.
Bogamuwa, Srimathi, Tanvir Hossain, Daniela Farkas, et al.. (2023). RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension. Journal of Clinical Investigation. 134(3). 17 indexed citations
5.
Gloag, Erin S., Jianying Li, Daniela Farkas, et al.. (2022). Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2. PLoS Pathogens. 18(3). e1010093–e1010093. 29 indexed citations
6.
Farkas, Daniela, et al.. (2022). MicroID2: A Novel Biotin Ligase Enables Rapid Proximity-Dependent Proteomics. Molecular & Cellular Proteomics. 21(7). 100256–100256. 16 indexed citations
7.
Link, Patrick A., Daniela Farkas, Brennan Harmon, et al.. (2022). Dichotomous role of integrin‐β5 in lung endothelial cells. Pulmonary Circulation. 12(4). e12156–e12156. 10 indexed citations
8.
Farkas, László, et al.. (2021). Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 22(22). 12098–12098. 30 indexed citations
9.
Farkas, Daniela, Brennan Harmon, Carlyne D. Cool, et al.. (2020). Clonally selected primitive endothelial cells promote occlusive pulmonary arteriopathy and severe pulmonary hypertension in rats exposed to chronic hypoxia. Scientific Reports. 10(1). 1136–1136. 16 indexed citations
10.
Farkas, Daniela, et al.. (2019). Endothelial cells are a source of Nestin expression in Pulmonary Arterial Hypertension. PLoS ONE. 14(3). e0213890–e0213890. 12 indexed citations
11.
Farkas, Daniela, A. A. Roger Thompson, Hyun Ji, et al.. (2018). Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 199(2). 199–210. 50 indexed citations
12.
Farkas, Daniela, Aysar Alhussaini, Donatas Kraskauskas, et al.. (2014). Nuclear Factor κB Inhibition Reduces Lung Vascular Lumen Obliteration in Severe Pulmonary Hypertension in Rats. American Journal of Respiratory Cell and Molecular Biology. 51(3). 413–425. 68 indexed citations
13.
Tian, Wen, Xinguo Jiang, Rasa Tamošiūnienė, et al.. (2013). Blocking Macrophage Leukotriene B 4 Prevents Endothelial Injury and Reverses Pulmonary Hypertension. Science Translational Medicine. 5(200). 200ra117–200ra117. 202 indexed citations
14.
Mizuno, Shiro, László Farkas, Daniela Farkas, et al.. (2012). Severe Pulmonary Arterial Hypertension Induced by SU5416 and Ovalbumin Immunization. American Journal of Respiratory Cell and Molecular Biology. 47(5). 679–687. 72 indexed citations
15.
Voelkel, Norbert F., et al.. (2012). Antioxidants for the Treatment of Patients with Severe Angioproliferative Pulmonary Hypertension?. Antioxidants and Redox Signaling. 18(14). 1810–1817. 33 indexed citations
16.
Bogaard, Harm Jan, Shiro Mizuno, Christophe Guignabert, et al.. (2011). Copper Dependence of Angioproliferation in Pulmonary Arterial Hypertension in Rats and Humans. American Journal of Respiratory Cell and Molecular Biology. 46(5). 582–591. 45 indexed citations
17.
Farkas, László & Martin Kolb. (2011). Pulmonary Microcirculation in Interstitial Lung Disease. Proceedings of the American Thoracic Society. 8(6). 516–521. 33 indexed citations
18.
Farkas, László, Jack Gauldie, Norbert F. Voelkel, & Martin Kolb. (2010). Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 45(1). 1–15. 168 indexed citations
19.
Farkas, László, Daniela Farkas, Kjetil Ask, et al.. (2009). VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. Journal of Clinical Investigation. 119(5). 1298–1311. 165 indexed citations
20.
Varga, László, et al.. (2001). Occurrence of Anaerobic Bacterial, Clostridial, and Clostridium perfringens Spores in Raw Goose Livers from a Poultry Processing Plant in Hungary. Journal of Food Protection. 64(8). 1252–1254. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian B. Graham Breakdown of academic impact, for papers by Clemens Ruppert Breakdown of academic impact, for papers by Yuh Fukuda Breakdown of academic impact, for papers by Hidenori Nakamura Breakdown of academic impact, for papers by Philipp Markart Breakdown of academic impact, for papers by Kjetil Ask Breakdown of academic impact, for papers by Huaping Dai Breakdown of academic impact, for papers by Kazuhiro Watanabe Breakdown of academic impact, for papers by Jacques Caen Breakdown of academic impact, for papers by Helmut Unruh
Rankless by CCL
2026